ORLY MISHAN
CIK 1830911 · Chief Business Officer · last filed 2025-03-21
ORLY MISHAN is a Chief Business Officer who has filed 2 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ADGM, was dated Mar 21, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
2
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADGM | Director | — | $0.74 | — | $0 | 1 | 2025-03-21 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Chief Business Officer | 38,450 | $18.07 | $694.8K | $0 | 1 | 2021-01-28 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-21 | ADGM | Grant (A) | — | $0 | EDGAR |
| 2021-01-28 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Exer (M) | +38,450 | $134.6K | EDGAR |